Report Detail
COVID-19 Impact on Global Preventive Vaccines Market Insights, Forecast to 2026
- RnM4064091 |
- 16 June, 2020 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Preventive Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Preventive Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Preventive Vaccines market is segmented into
Intramuscular Injection
Nasal Spray
Intradermal Shot
Segment by Application, the Preventive Vaccines market is segmented into
Hospital
Clinic
Other
Regional and Country-level Analysis
The Preventive Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Preventive Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Preventive Vaccines Market Share Analysis
Preventive Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Preventive Vaccines business, the date to enter into the Preventive Vaccines market, Preventive Vaccines product introduction, recent developments, etc.
The major vendors covered:
Sanofi
AstraZeneca
CSL Ltd
Abbott
GlaxoSmithKline
Serum Institute of India
...
1 Study Coverage
- 1.1 Preventive Vaccines Product Introduction
- 1.2 Market Segments
- 1.3 Key Preventive Vaccines Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Preventive Vaccines Market Size Growth Rate by Type
- 1.4.2 Intramuscular Injection
- 1.4.3 Nasal Spray
- 1.4.4 Intradermal Shot
- 1.5 Market by Application
- 1.5.1 Global Preventive Vaccines Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Other
- 1.6 Coronavirus Disease 2019 (Covid-19): Preventive Vaccines Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Preventive Vaccines Industry
- 1.6.1.1 Preventive Vaccines Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Preventive Vaccines Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Preventive Vaccines Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Preventive Vaccines Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Preventive Vaccines Market Size Estimates and Forecasts
- 2.1.1 Global Preventive Vaccines Revenue 2015-2026
- 2.1.2 Global Preventive Vaccines Sales 2015-2026
- 2.2 Preventive Vaccines Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Preventive Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Preventive Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Preventive Vaccines Competitor Landscape by Players
- 3.1 Preventive Vaccines Sales by Manufacturers
- 3.1.1 Preventive Vaccines Sales by Manufacturers (2015-2020)
- 3.1.2 Preventive Vaccines Sales Market Share by Manufacturers (2015-2020)
- 3.2 Preventive Vaccines Revenue by Manufacturers
- 3.2.1 Preventive Vaccines Revenue by Manufacturers (2015-2020)
- 3.2.2 Preventive Vaccines Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Preventive Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Preventive Vaccines Revenue in 2019
- 3.2.5 Global Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Preventive Vaccines Price by Manufacturers
- 3.4 Preventive Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 Preventive Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Preventive Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into Preventive Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Preventive Vaccines Market Size by Type (2015-2020)
- 4.1.1 Global Preventive Vaccines Sales by Type (2015-2020)
- 4.1.2 Global Preventive Vaccines Revenue by Type (2015-2020)
- 4.1.3 Preventive Vaccines Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Preventive Vaccines Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Preventive Vaccines Sales Forecast by Type (2021-2026)
- 4.2.2 Global Preventive Vaccines Revenue Forecast by Type (2021-2026)
- 4.2.3 Preventive Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Preventive Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Preventive Vaccines Market Size by Application (2015-2020)
- 5.1.1 Global Preventive Vaccines Sales by Application (2015-2020)
- 5.1.2 Global Preventive Vaccines Revenue by Application (2015-2020)
- 5.1.3 Preventive Vaccines Price by Application (2015-2020)
- 5.2 Preventive Vaccines Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Preventive Vaccines Sales Forecast by Application (2021-2026)
- 5.2.2 Global Preventive Vaccines Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Preventive Vaccines Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Preventive Vaccines by Country
- 6.1.1 North America Preventive Vaccines Sales by Country
- 6.1.2 North America Preventive Vaccines Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Preventive Vaccines Market Facts & Figures by Type
- 6.3 North America Preventive Vaccines Market Facts & Figures by Application
7 Europe
- 7.1 Europe Preventive Vaccines by Country
- 7.1.1 Europe Preventive Vaccines Sales by Country
- 7.1.2 Europe Preventive Vaccines Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Preventive Vaccines Market Facts & Figures by Type
- 7.3 Europe Preventive Vaccines Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Preventive Vaccines by Region
- 8.1.1 Asia Pacific Preventive Vaccines Sales by Region
- 8.1.2 Asia Pacific Preventive Vaccines Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Preventive Vaccines Market Facts & Figures by Type
- 8.3 Asia Pacific Preventive Vaccines Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Preventive Vaccines by Country
- 9.1.1 Latin America Preventive Vaccines Sales by Country
- 9.1.2 Latin America Preventive Vaccines Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Preventive Vaccines Market Facts & Figures by Type
- 9.3 Central & South America Preventive Vaccines Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Preventive Vaccines by Country
- 10.1.1 Middle East and Africa Preventive Vaccines Sales by Country
- 10.1.2 Middle East and Africa Preventive Vaccines Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Preventive Vaccines Market Facts & Figures by Type
- 10.3 Middle East and Africa Preventive Vaccines Market Facts & Figures by Application
11 Company Profiles
- 11.1 Sanofi
- 11.1.1 Sanofi Corporation Information
- 11.1.2 Sanofi Description, Business Overview and Total Revenue
- 11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Sanofi Preventive Vaccines Products Offered
- 11.1.5 Sanofi Recent Development
- 11.2 AstraZeneca
- 11.2.1 AstraZeneca Corporation Information
- 11.2.2 AstraZeneca Description, Business Overview and Total Revenue
- 11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 AstraZeneca Preventive Vaccines Products Offered
- 11.2.5 AstraZeneca Recent Development
- 11.3 CSL Ltd
- 11.3.1 CSL Ltd Corporation Information
- 11.3.2 CSL Ltd Description, Business Overview and Total Revenue
- 11.3.3 CSL Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 CSL Ltd Preventive Vaccines Products Offered
- 11.3.5 CSL Ltd Recent Development
- 11.4 Abbott
- 11.4.1 Abbott Corporation Information
- 11.4.2 Abbott Description, Business Overview and Total Revenue
- 11.4.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Abbott Preventive Vaccines Products Offered
- 11.4.5 Abbott Recent Development
- 11.5 GlaxoSmithKline
- 11.5.1 GlaxoSmithKline Corporation Information
- 11.5.2 GlaxoSmithKline Description, Business Overview and Total Revenue
- 11.5.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 GlaxoSmithKline Preventive Vaccines Products Offered
- 11.5.5 GlaxoSmithKline Recent Development
- 11.6 Serum Institute of India
- 11.6.1 Serum Institute of India Corporation Information
- 11.6.2 Serum Institute of India Description, Business Overview and Total Revenue
- 11.6.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Serum Institute of India Preventive Vaccines Products Offered
- 11.6.5 Serum Institute of India Recent Development
- 11.1 Sanofi
- 11.1.1 Sanofi Corporation Information
- 11.1.2 Sanofi Description, Business Overview and Total Revenue
- 11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Sanofi Preventive Vaccines Products Offered
- 11.1.5 Sanofi Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Preventive Vaccines Market Estimates and Projections by Region
- 12.1.1 Global Preventive Vaccines Sales Forecast by Regions 2021-2026
- 12.1.2 Global Preventive Vaccines Revenue Forecast by Regions 2021-2026
- 12.2 North America Preventive Vaccines Market Size Forecast (2021-2026)
- 12.2.1 North America: Preventive Vaccines Sales Forecast (2021-2026)
- 12.2.2 North America: Preventive Vaccines Revenue Forecast (2021-2026)
- 12.2.3 North America: Preventive Vaccines Market Size Forecast by Country (2021-2026)
- 12.3 Europe Preventive Vaccines Market Size Forecast (2021-2026)
- 12.3.1 Europe: Preventive Vaccines Sales Forecast (2021-2026)
- 12.3.2 Europe: Preventive Vaccines Revenue Forecast (2021-2026)
- 12.3.3 Europe: Preventive Vaccines Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Preventive Vaccines Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Preventive Vaccines Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Preventive Vaccines Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Preventive Vaccines Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Preventive Vaccines Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Preventive Vaccines Sales Forecast (2021-2026)
- 12.5.2 Latin America: Preventive Vaccines Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Preventive Vaccines Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Preventive Vaccines Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Preventive Vaccines Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Preventive Vaccines Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Preventive Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Preventive Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Preventive Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Preventive Vaccines. Industry analysis & Market Report on COVID-19 Impact on Global Preventive Vaccines is a syndicated market report, published as COVID-19 Impact on Global Preventive Vaccines Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Preventive Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
